A phase II study of capecitabine-oxaliplatin and cetuximab in patients (pts) with advanced/metastatic gastric cancer (G) or gastroesophageal junction (GEJ) adenocarcinoma.

被引：0
|
作者：
Iqbal, Syma [1 ]
El-Khoueiry, Anthony B. [1 ]
Yang, Dongyun [1 ]
Paez, David [1 ]
Duddalwar, Vinay [1 ]
Zhang, Wu [1 ]
Agafitei, Raluca Dana [1 ]
Lujan, Ramona [1 ]
Cole, Sarah [1 ]
Ning, Yan [1 ]
El-Khoueiry, Rita [1 ]
Loupakis, Fotios [1 ]
Wakatsuki, Takeru [1 ]
Lenz, Heinz-Josef [1 ]
机构：
[1] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4096
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Docetaxel, oxaliplatin, and capecitabine (DOX) combination chemotherapy for metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.
    Di Lauro, Luigi
    Sergi, Domenico
    Belli, Franca
    Fattoruso, Silvia Ileana
    Arena, Maria Grazia
    Pizzuti, Laura
    Vici, Patrizia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A phase II study of capecitabine, carboplatin, and bevacizumab for metastatic or unresectable gastroesophageal junction and gastric adenocarcinoma.
    Kunz, Pamela L.
    Nandoskar, Prachi
    Koontz, Michael Zach
    Ji, Hanlee
    Ford, James M.
    Balise, Raymond R.
    Kamaya, Aya
    Rubin, Daniel
    Fisher, George A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [3] Epirubicin, oxaliplatin, and docetaxel (EOD) combination in metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma: A phase II study
    Di Lauro, L.
    Giacinti, L.
    Arena, M. G.
    Fattoruso, S. I.
    Foggi, P.
    Lopez, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.
    Li, Hongli
    Deng, Jingyu
    Ge, Shaohua
    Zang, Fenglin
    Zhang, Le
    Ren, Peng
    Wang, Baogui
    Cao, Fuliang
    Deng, Ting
    Liu, Rui
    Ning, Tao
    Yang, Yuchong
    Bai, Ming
    Wang, Xia
    Ji, Zhi
    Duan, Jingjing
    Liu, Yong
    Zhou, Dejun
    Liang, Han
    Ba, Yi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] A phase II study of bevacizumab, docetaxel and oxaliplatin in gastric and gastroesophageal junction (GEJ) cancer
    El-Rayes, B. F.
    Hammad, N.
    Philip, P. A.
    Shields, A. F.
    Heilbrun, L. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] A phase II study of TAS-102 in combination with ramucirumab in advanced, refractory gastric or gastroesophageal junction (GEJ) adenocarcinoma.
    Mehta, Rutika
    Kim, Richard D.
    Shah, Neal
    Carballido, Estrella M.
    Kim, Youngchul
    Imanirad, Iman
    Kim, Dae Won
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Phase II study of cetuximab in combination with cisplatin and docetaxel as first-line treatment in patients with locally advanced/metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Pinto, C.
    Di Fabio, F.
    Barone, C.
    Siena, S.
    Falcone, A.
    Cascinu, S.
    Rojas, Llimpe F.
    Artale, S.
    Schinzari, G.
    Giaquinta, S.
    Mutri, V
    Martoni, A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 9 - 9
  • [8] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
  • [9] A PROSPECTIVE PHASE II STUDY OF CETUXIMAB IN COMBINATION WITH XELOX (CAPECITABINE AND OXALIPLATIN) IN PATIENTS WITH METASTATIC AND/OR RECURRENT ADVANCED GASTRIC CANCER
    Kim, C.
    Lee, J.
    Ryu, M.
    Chang, H. M.
    Kim, T. W.
    Kang, H. J.
    Lim, H. Y.
    Park, Y. S.
    Ryoo, B.
    Kang, Y.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [10] A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
    Kim, Chul
    Lee, Jae-Lyun
    Ryu, Min-Hee
    Chang, Heung Moon
    Kim, Tae Won
    Lim, Ho Young
    Kang, Hye Jin
    Park, Young Suk
    Ryoo, Baek-Yeol
    Kang, Yoon-Koo
    [J]. INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 366 - 373
12345